Ramesh Hariharan
Corporate Officer/Principal chez NATERA, INC.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Matthew Rabinowitz | M | 51 | 21 ans | |
Stephen Chapman | M | 45 | 14 ans | |
Herm Rosenman | M | 76 | 10 ans | |
Michael Brophy | M | 44 | 9 ans | |
Jonathan Sheena | M | 51 | 21 ans | |
James Healy | M | 59 | 10 ans | |
Roelof Botha | M | 50 | 17 ans | |
Paul Greenland | M | - | - | |
Olesya Anisimova | F | - | 9 ans | |
Daniel Rabinowitz | M | 55 | 20 ans | |
Solomon Moshkevich | M | - | 13 ans | |
Gail Marcus | M | 67 | 7 ans | |
Roy Baynes | M | 69 | 6 ans | |
Ruth Williams-Brinkley | F | 72 | 1 ans | |
Rowan Chapman | M | 53 | 5 ans | |
Rishi Kacker | M | - | - | |
Eric Evans | M | - | 4 ans | |
Phil Grinnell | M | - | 13 ans | |
Robert Schueren | M | 62 | 5 ans | |
Lesley Bogdanow | F | - | - | |
Minetta Liu | M | - | 2 ans | |
John Fesko | M | - | 1 ans | |
Alexey Aleshin | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Nicolas Barthelemy | M | 58 |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 3 ans |
Veena M. Singh | M | 49 |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 5 ans |
Debbie Ledet | F | 58 |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | 5 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 26 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ramesh Hariharan
- Réseau Personnel